Becton, Dickinson And Company (BDX) fundamentals score
BD is a global medical technology company engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.
Surgical & Medical Instruments & Apparatus · Healthcare · Listed on NYSE
Overall: 6.1 out of 10, Mixed fundamentals
- Growth: 5.3/10
- Profitability: 6.0/10
- Financial health: 5.9/10
- Earnings quality: 9.8/10
- Valuation: 4.4/10
Scores are calculated from Becton, Dickinson And Company’s SEC filings, using the 12 months through 2026-06. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.
Other Healthcare stocks
- Nurix Therapeutics, Inc. (NRIX): 9.0/10
- Caredx, Inc. (CDNA): 8.9/10
- Dexcom, Inc. (DXCM): 8.8/10
- Exelixis Inc. (EXEL): 8.8/10
- Neurocrine Biosciences Inc. (NBIX): 8.7/10
- Progyny, Inc. (PGNY): 8.6/10
- Healthcare Services Group, Inc. (HCSG): 8.5/10
- Insulet Corporation (PODD): 8.5/10